The enzyme mieloperoxidasa like important biomarcador in the medical services of health
Keywords:
Benefits, Enzyme, Mieloperoxidasa, Services Of HealthAbstract
Introduction: the technological advances in the environment of the microscopic medicine have allowed going into in the molecular operation of the cellular processes, where they play a fundamental paper the enzymatic proteins. The mieloperoxidasa is a hemoprotein that is stored mainly in the granules azurofilos of the neutrophils human polimorfonucleares, monocytes and macrophages.
Objective: to characterize the enzyme mieloperoxidasa like important biomarcador for the diagnosis of illnesses in the medical services of health.
Methodological design: he/she was carried out a bibliographical revision understood in the period of July to August of the 2023, where original articles, case reports and systematic revisions of access were consulted opened up in academic publications revised for even, of the last 5 years. The databases of SciELO were revised, Regmed, Dialnet, Mayoclinic, among others.
Development: the activity of the MPO is used, a while ago, as a marker that indicates the presence of inflammatory processes. It plays a preponderant list in the fisiopatologia of the COVID-19. High levels are in several illnesses, among those that he/she is distinguished the cancer. The MPO, it could contribute to the defense mechanism against infectious agents, as well as to favor the pathogenesis from the illness when causing damage to the adjacent fabrics.
Conclusions: the activity of the enzyme mieloperoxidasa was significant as marker of cardiovascular risk, cancer, inflammatory processes and he/she has activity predictor with regard to the vascular damage. Also it has served as reference as marker presage of graveness of the COVID-19.
Downloads
References
2. Carreño MR, Benavides ER, Peña CG, Florentini A, Fernández Y, Esquerre CG, et al. Asociación de mieloperoxidasa sérica con variables cardiometabólicas en dos poblaciones: Carhuamayo (4100 m - Junín) y Mala (30 m - Lima). Rev Soc Quím del Perú [Internet]. 2020 [citado 14/05/2023]: [aprox. 15 p.]. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1810-634X2017000100004&nrm=iso
3. García Morales OH, Pereira Roche N, Flores Sánchez RM. Enzimas generadoras de especies reactivas del oxígeno: mieloperoxidasa. Rev Cub de Inv Biom [Internet]. 2020 [citado 14/05/2023]: [aprox. 11 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03001998000300002&nrm=iso
4. Galán A, Curós A, Valle V. Biomarcadores de detección y predicción de síndrome coronario agudo. Med Clin [Internet]. 2020 [citado 14/05/2023]; 134(11):[aprox. 5 p.]. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/ibc-82785
5. Cárdenas PA, Aragón DM, Ospina LF, Isaza G, Pérez JE. Efecto de algunas especies vegetales antiinflamatorias sobre la actividad enzimática de elastasa y mieloperoxidasa. Rev colomb cienc quím [Internet]. 2019 [citado 14/05/2023]; 41:157-66. Disponible en: https://www.virtualpro.co/revista/revista-colombiana-de-ciencias-quimicofarmaceuticas-vol-41-no-2/6
6. González Fanjul A, Cabrera Llano JL, Barreto Fiu E, Fanjul Losada NM, Rodríguez Hernández M & Jaime Valdés L. Mieloperoxidasa como marcador de daño vascular. [Internet]. 2019 [citado 17/05/2023]; 12:(2). Disponible en: https://revactamedicacentro.sld.cu/index.php/amc/article/view/900/1133
7. González Fanjul A, Fanjul Lozada NM, Jaime Valdés LM, Garcés Guerra O, Álvarez Abreu A, Pérez León I. Actividad de la enzima Mieloperoxidas en trabajadores. Acta Medica del Centro. [Internet]. 2019 [citado 17/05/2023]; 13(3):367-373. Disponible en: https://revactamedicacentro.sld.cu/index.php/amc/article/view/1025
8. Victor VM, Rovira-Llopis S, Bañuls C, Diaz-Morales N, Martinez de Marañon A, RiosNavarro C, et al. Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase. PLoS One [Internet]. 2016 [citado 17/05/2023];11(3).Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805297/
9. Ventura Base A, Aroche Aportela R, Rodríguez Navarro AY. Utilidad del riesgo cardiovascular en la predicción de la enfermedad arterial coronaria. CorSalud [Internet]. 2019 [citado 17/05/2023]; 3(2): [aprox. 18p.]. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=3738978
10. Reynolds WF, Kumar AP, Piedrafita FJ. The human myeloperoxidase gene is regulated by LXR and PPARα ligands. Biochem Biophys Res Commun. 2018 [citado 17/05/2023]; 49:846–854. Disponible en: https://pubmed.ncbi.nlm.nih.gov/16956579/
11. Ndrepepa G. Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease. Clin Chim Acta. [Internet]. 2019 [citado 17/05/2023]; 493:36-51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30797769/
12. Valadez-Cosmes P, Raftopoulou S, Mihalic ZN, Marsche G, Kargl J. Myeloperoxidase: Growing importance in cancer pathogenesis and potential drug target. Pharmacol Ther. [Internet]. 2022 [citado 17/05/2023]; 236:108052. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34890688/
13. Thanat Chaikijurajai, W. H. Wilson Tang. Myeloperoxidase: a potential therapeutic target for coronary artery disease. Expert Opin Ther Targets. [Internet]. 2020 [citado 17/05/2023]; 24(7): 695–705. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387188/
14. Buso G, Faggin E, Rosenblatt-Velin N, et al. The Role of Neutrophils in Lower Limb Peripheral Artery Disease: State of the Art and Future Perspectives. Int J Mol Sci [Internet]. 2023 [citado 17/05/2023]; 24(2):1169. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36674682/
15. Zhang N, Aiyasiding X, Li WJ, Liao HH, Tang QZ. Neutrophil degranulation and myocardial infarction. Cell Commun Signal. [Internet]. 2022 [citado 17/05/2023]; 20(1):50. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35410418/
Downloads
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal accept the following terms: The authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Recognition License. Creative Commons that allows third parties to share the work as long as its author and its first publication in this magazine are indicated. Authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and recommended to disseminate their work through the Internet (e.g.: in institutional telematic archives or on your website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work.
